“Providing rapid diagnosis to ensures doctors or disease control organizations can respond by making swift and effective healthcare decisions” has always been the core value of Sanwa BioTech. This has stand true especially in the COVID-19 pandemic as we demonstrate to the public through our interview with South China Morning Post on how the team at Sanwa had been working around the clock to provide ALiA platform as a diagnostic device to help people battle the deadly coronavirus disease and improve general health.
ALiA BioTech at 2023 AACC Clinical Expo
We are delighted to share with you the successful exhibition
